driven by the PitchBook Platform
Developer of an anti-cancer drug. The company develops a anti-cancer drug by fusing an antibody to the paclitaxel molecule.
You’re viewing a free company profile from the PitchBook Platform. To explore Aomics’s full profile, request a free trial.
© 2018 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.